HUMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.00%

Insider Buying (Last 12 Months): $124,978.00

Insider Selling (Last 12 Months): $8,819,000.00

Humacyte Insider Trading History Chart

Humacyte Share Price & Price History

^$3.07

▲ +0.1 (3.37%)

As of 12/8/2022 01:00 AM ET

Days: 30 | 90 | 365

The Critical Minerals Race: U.S. v China

From Investing Trends | Ad

The U.S. is dangerously lacking in critical minerals such as cobalt, lithium, and rare earths needed to maintain our national security. China is aggressively locking up mines and production. But the U.S. is about to strike back with a forceful plan of action to increase domestic production.

See how investors could can take advantage

Humacyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2022	Brady W. Dougan	Director	Sell	1,522,500	$4.00	$6,090,000.00	18,930,004
9/15/2022	Laura E. Niklason	CEO	Buy	2,000	$4.14	$8,280.00	1,160,240
5/24/2022	William John Scheessele	Insider	Buy	10,525	$4.72	$49,678.00	10,525
5/23/2022	Laura E. Niklason	CEO	Buy	10,000	$4.83	$48,300.00	1,158,240
5/23/2022	Michael T. Constantino	Director	Buy	2,000	$4.83	$9,660.00	4,500
5/17/2022	Dale A Sander	CFO	Buy	2,000	$4.53	$9,060.00	2,000
12/16/2021	Brady W. Dougan	Director	Sell	75,000	$9.00	$675,000.00
12/15/2021	Laura E. Niklason	CEO	Sell	125,000	$8.88	$1,110,000.00
12/14/2021	Brady W. Dougan	Director	Sell	100,000	$9.44	$944,000.00
11/22/2021	Michael T. Constantino	Director	Buy	2,500	$10.79	$26,975.00

Elon Musk Sees Serious Crisis

From Investing Trends | Ad

When Tesla's Elon Musk says there's a major shortage of a key material used in electric vehicles...and says prices for this material are "CRAZY"...you can bet there's an incredible investment opportunity in that crisis.

Discover how you can take advantage of lithium

SEC Filings (Institutional Ownership Changes) for Humacyte (NASDAQ:HUMA)

13.05% of Humacyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Humacyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/8/2022	Bank of New York Mellon Corp	69,776	$0.23M	0.0%	+24.1%	0.068%
11/15/2022	Marshall Wace LLP	192,530	$0.63M	0.0%	+227.3%	0.187%
11/15/2022	Bank of New York Mellon Corp	69,776	$0.23M	0.0%	+24.1%	0.068%
11/15/2022	BlackRock Inc.	2,211,355	$7.21M	0.0%	-7.7%	2.147%
11/14/2022	Renaissance Technologies LLC	208,000	$0.68M	0.0%	+1,773.9%	0.202%
11/14/2022	Ergoteles LLC	31,276	$0.10M	0.0%	N/A	0.030%
11/14/2022	Nuveen Asset Management LLC	85,846	$0.28M	0.0%	-4.2%	0.083%
11/14/2022	UBS Oconnor LLC	595,172	$1.94M	0.0%	-45.9%	0.578%
11/14/2022	York Capital Management Global Advisors LLC	1,399,424	$4.56M	1.0%	-38.9%	1.359%
11/10/2022	UBS Group AG	9,827	$32K	0.0%	+92.0%	0.010%
11/8/2022	Hamilton Lane Advisors LLC	52,693	$0.17M	0.1%	N/A	0.051%
11/8/2022	New York State Common Retirement Fund	14,400	$47K	0.0%	-48.4%	0.014%
11/3/2022	Teacher Retirement System of Texas	18,343	$60K	0.0%	N/A	0.018%
10/31/2022	SG Americas Securities LLC	10,826	$35K	0.0%	N/A	0.011%
10/20/2022	Gladstone Institutional Advisory LLC	87,423	$0.29M	0.0%	-36.4%	0.085%
8/22/2022	Legal & General Group Plc	16,970	$55K	0.0%	+24.7%	0.016%
8/18/2022	Goldman Sachs Group Inc.	42,903	$0.14M	0.0%	-55.3%	0.042%
8/16/2022	Jane Street Group LLC	19,040	$61K	0.0%	-56.1%	0.018%
8/16/2022	Josh Arnold Investment Consultant LLC	22,000	$71K	0.1%	-39.2%	0.021%
8/15/2022	State Street Corp	418,042	$1.34M	0.0%	+73.3%	0.406%
8/15/2022	Cubist Systematic Strategies LLC	19,500	$63K	0.0%	-59.6%	0.019%
8/15/2022	Millennium Management LLC	398,765	$1.28M	0.0%	+40.6%	0.387%
8/15/2022	UBS Asset Management Americas Inc.	15,947	$51K	0.0%	+17.3%	0.015%
8/13/2022	Renaissance Technologies LLC	11,100	$36K	0.0%	-76.4%	0.011%
8/13/2022	American International Group Inc.	8,260	$27K	0.0%	N/A	0.008%
8/12/2022	Northern Trust Corp	242,389	$0.78M	0.0%	+98.5%	0.235%
8/12/2022	LPL Financial LLC	297,540	$0.96M	0.0%	N/A	0.289%
8/12/2022	Credit Suisse AG	43,116	$0.14M	0.0%	+15.0%	0.042%
8/12/2022	Rhumbline Advisers	21,430	$69K	0.0%	N/A	0.021%
8/9/2022	Swiss National Bank	133,500	$0.43M	0.0%	+9.6%	0.130%
8/3/2022	Valley Forge Investment Consultants Inc. ADV	11,000	$35K	0.0%	N/A	0.011%
8/2/2022	Powell Investment Advisors LLC	14,000	$45K	0.0%	N/A	0.014%
7/13/2022	Private Advisor Group LLC	24,500	$79K	0.0%	N/A	0.024%
6/7/2022	Bank of America Corp DE	23,904	$0.17M	0.0%	+247.1%	0.023%
5/17/2022	Mirabella Financial Services LLP	10,244	$72K	0.0%	N/A	0.010%
5/17/2022	Prescott General Partners LLC	625,100	$4.41M	0.2%	+681.4%	0.607%
5/17/2022	Ensign Peak Advisors Inc	7,940	$56K	0.0%	N/A	0.008%
5/17/2022	Eudaimonia Partners LLC	10,302	$73K	0.0%	N/A	0.010%
5/16/2022	California State Teachers Retirement System	50,998	$0.36M	0.0%	+16.5%	0.050%
5/16/2022	Goldman Sachs Group Inc.	95,966	$0.68M	0.0%	+23.5%	0.093%
5/16/2022	State Street Corp	241,203	$1.70M	0.0%	+246.2%	0.234%
5/13/2022	Renaissance Technologies LLC	47,100	$0.33M	0.0%	+218.2%	0.046%
5/13/2022	Northern Trust Corp	122,089	$0.86M	0.0%	-1.8%	0.119%
5/13/2022	Charles Schwab Investment Management Inc.	301,642	$2.13M	0.0%	+2.5%	0.293%
5/13/2022	Vanguard Group Inc.	2,422,020	$17.10M	0.0%	+107.3%	2.351%
5/12/2022	Josh Arnold Investment Consultant LLC	36,171	$0.26M	0.2%	N/A	0.035%
5/12/2022	BlackRock Inc.	1,577,919	$11.14M	0.0%	+12.6%	1.532%
5/12/2022	Citigroup Inc.	11,859	$84K	0.0%	+191.7%	0.012%
5/11/2022	Bank of New York Mellon Corp	26,642	$0.19M	0.0%	N/A	0.026%
5/10/2022	ProShare Advisors LLC	10,660	$75K	0.0%	-26.5%	0.010%
5/9/2022	Swiss National Bank	121,800	$0.86M	0.0%	+7.4%	0.118%
5/4/2022	Advisor Group Holdings Inc.	25,020	$0.18M	0.0%	+24.6%	0.024%
5/4/2022	Wolverine Asset Management LLC	11,213	$79K	0.0%	-14.7%	0.011%
5/4/2022	Gladstone Institutional Advisory LLC	144,867	$1.02M	0.1%	-41.3%	0.141%
4/29/2022	United Asset Strategies Inc.	14,960	$0.11M	0.0%	+45.1%	0.015%
4/28/2022	Alphastar Capital Management LLC	10,767	$76K	0.0%	N/A	0.010%
4/26/2022	Sciencast Management LP	26,300	$0.18M	0.0%	N/A	0.026%
4/22/2022	Kovitz Investment Group Partners LLC	11,550	$82K	0.0%	N/A	0.011%
4/13/2022	Exos Asset Management LLC	18,609	$0.13M	0.1%	+15.3%	0.018%
4/4/2022	Dixon Hughes Goodman Wealth Advisors LLC	6,750	$48K	0.0%	N/A	0.007%
3/14/2022	Exos Asset Management LLC	16,139	$0.12M	0.1%	-14.8%	0.016%
2/15/2022	Diameter Capital Partners LP	300,338	$2.18M	0.1%	-68.5%	0.292%
2/14/2022	Prescott General Partners LLC	80,000	$0.58M	0.0%	N/A	0.078%
2/14/2022	LMR Partners LLP	36,960	$0.27M	0.0%	N/A	0.036%
2/14/2022	Maven Securities LTD	200,000	$1.45M	0.0%	-60.0%	0.194%
2/11/2022	Endowment Wealth Management Inc.	96,618	$0.70M	0.7%	N/A	0.094%
2/10/2022	Teacher Retirement System of Texas	10,073	$73K	0.0%	N/A	0.010%
2/9/2022	Wolverine Asset Management LLC	13,150	$95K	0.0%	N/A	0.013%
2/9/2022	Philadelphia Trust Co.	10,000	$73K	0.0%	-33.3%	0.010%
2/8/2022	Swiss National Bank	113,400	$0.82M	0.0%	N/A	0.110%
2/8/2022	ProShare Advisors LLC	14,506	$0.11M	0.0%	N/A	0.014%
2/8/2022	Northern Trust Corp	124,376	$0.90M	0.0%	N/A	0.121%
2/7/2022	Monashee Investment Management LLC	399,910	$2.90M	0.7%	-46.7%	0.388%
2/4/2022	Arizona State Retirement System	13,862	$100K	0.0%	N/A	0.013%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	13,230	$96K	0.0%	N/A	0.013%
11/16/2021	LPL Financial LLC	114,615	$1.33M	0.0%	N/A	0.111%
11/16/2021	CVI Holdings LLC	500,000	$5.81M	0.4%	N/A	0.485%
11/15/2021	York Capital Management Global Advisors LLC	2,291,397	$20.59M	2.2%	N/A	2.225%
11/10/2021	Citigroup Inc.	4,062	$47K	0.0%	N/A	0.004%
11/9/2021	Monashee Investment Management LLC	750,000	$8.71M	1.6%	N/A	0.728%
11/5/2021	Advisor Group Holdings Inc.	18,224	$0.21M	0.0%	N/A	0.018%
10/28/2021	Kovitz Investment Group Partners LLC	11,050	$0.13M	0.0%	N/A	0.086%
10/25/2021	Exos Asset Management LLC	18,942	$0.22M	0.1%	N/A	0.147%
10/25/2021	Eudaimonia Partners LLC	25,038	$0.29M	0.1%	N/A	0.195%
10/21/2021	United Asset Strategies Inc.	10,308	$0.12M	0.0%	N/A	0.080%

Data available starting January 2016

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Today's Range

Now: $3.07

$2.93

$3.10

50 Day Range

MA: $3.23

$2.87

$3.62

52 Week Range

Now: $3.07

$2.78

$10.92

Volume

167,235 shs

Average Volume

284,182 shs

Market Capitalization

$316.58 million

P/E Ratio

9.59

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Humacyte?: Humacyte's top insider investors include:
Brady W Dougan (Director)
Laura E Niklason (CEO)
William John Scheessele (Insider)
Michael T Constantino (Director)
Dale A Sander (CFO)
Learn More about top insider investors at Humacyte.
Who are the major institutional investors of Humacyte?: Humacyte's top institutional shareholders include:
BlackRock Inc. — 2.15%
York Capital Management Global Advisors LLC — 1.36%
UBS Oconnor LLC — 0.58%
Renaissance Technologies LLC — 0.20%
Marshall Wace LLP — 0.19%
Group One Trading L.P. — 0.00%
Learn More about top institutional investors of Humacyte stock.
Which major investors are selling Humacyte stock?: In the last quarter, HUMA stock was sold by these institutional investors:
York Capital Management Global Advisors LLC
UBS Oconnor LLC
BlackRock Inc.
Gladstone Institutional Advisory LLC
New York State Common Retirement Fund
Group One Trading L.P.
Nuveen Asset Management LLC
Within the last year, company insiders that have sold Humacyte company stock include:
Brady W Dougan (Director)
Laura E Niklason (CEO)
Learn More investors selling Humacyte stock.
Which major investors are buying Humacyte stock?: In the previous quarter, HUMA stock was purchased by institutional investors including:
Renaissance Technologies LLC
Marshall Wace LLP
Hamilton Lane Advisors LLC
Ergoteles LLC
Simplex Trading LLC
Teacher Retirement System of Texas
Bank of New York Mellon Corp
Bank of New York Mellon Corp
In the last year, these company insiders have bought Humacyte stock:
Brady W Dougan (Director)
Laura E Niklason (CEO)
William John Scheessele (Insider)
Michael T Constantino (Director)
Learn More investors buying Humacyte stock.